Re: Long Term Effectiveness and Safety of Intracavernosal Botulinum Toxin A as an Add-on Therapy to Phosphosdiesterase Type 5 Inhibitors or Prostaglandin E1 Injections for Erectile Dysfunction Editorial Comment

被引：0

|

作者：

不详

机构：

来源：

JOURNAL OF UROLOGY | 2022年 / 207卷 / 05期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：1138 / 1139

页数：2

相关论文

共 10 条

[1] Long Term Effectiveness and Safety of Intracavernosal Botulinum Toxin A as an Add-on Therapy to Phosphosdiesterase Type 5 Inhibitors or Prostaglandin E1 Injections for Erectile Dysfunction
Giuliano, Francois
Joussain, Charles
Denys, Pierre
JOURNAL OF SEXUAL MEDICINE, 2022, 19 (01): : 83 - 89
[2] LONG TERM EFFECTIVENESS AND SAFETY OF INTRACAVERNOSAL BOTULINUM TOXIN A AS AN ADD-ON THERAPY TOPHOSPHOSDIESTERASE TYPE 5 INHIBITORS OR PROSTAGLANDIN E1 INJECTIONS FOR ERECTILE DYSFUNCTION - A CASE SERIES STUDY
Giuliano, Francois
Joussain, Charles
Denys, Pierre
JOURNAL OF SEXUAL MEDICINE, 2022, 19 (11): : S11 - S11
[3] SAFETY AND EFFICACY OF INTRACAVERNOSAL INJECTIONS OF ABOBOTULINUMTOXINA (DYSPORT®) AS ADD ON THERAPY TO PHOSPHOSDIESTERASE TYPE 5 INHIBITORS OR PROSTAGLANDIN E1 FOR ERECTILE DYSFUNCTION - CASE STUDIES
Giuliano, F.
Joussain, C.
Denys, P.
JOURNAL OF SEXUAL MEDICINE, 2020, 17 (06): : S137 - S137
[4] Safety and Efficacy of Intracavernosal Injections of AbobotulinumtoxinA (Dysport®) as Add on Therapy to Phosphosdiesterase Type 5 Inhibitors or Prostaglandin E1 for Erectile DysfunctionCase Studies
Giuliano, Francois
Joussain, Charles
Denys, Pierre
TOXINS, 2019, 11 (05):
[5] Penile fibrosis in intracavernosal prostaglandin E1 injection therapy for erectile dysfunction - Comment
Porst, H
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 1997, 9 (04) : 229 - 230
[6] Intracavernosal prostaglandin injections E1 of the long course in treatment of erectile dysfunction: total satisfaction and quality of sexual life of the patients, EASY study.
Alexandre, B
Lemaire, A
Amar, T
Desvaux, P
DIABETES & METABOLISM, 2006, 32 : S92 - S92
[7] Intracavernous injections of prostaglandin E1 for erectile dysfunction: Patient satisfaction and quality of sex life on long-term treatment
Alexandre, Benjamin
Lemaire, Antoine
Desvaux, Pierre
Amar, Edouard
JOURNAL OF SEXUAL MEDICINE, 2007, 4 (02): : 426 - 431
[8] Re: Comparative Effectiveness and Safety of Oral Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction: A Systematic Review and Network Meta-Analysis Editorial Comment
Seftel, Allen
JOURNAL OF UROLOGY, 2013, 190 (04): : 1340 - 1340
[9] Long-term efficacy and safety of self-intracavernous injection of prostaglandin E1 for treatment of erectile dysfunction in China
He, L.
Wen, J.
Jiang, X.
Chen, H.
Tang, Y.
ANDROLOGIA, 2011, 43 (03) : 208 - 212
[10] Prostaglandin E1 long-term self-injection programme for treatment of erectile dysfunction - a follow-up of at least 5 years
Hauck, EW
Altinkilic, BM
Schroeder-Printzen, I
Rudnick, J
Weidner, W
ANDROLOGIA, 1999, 31 : 99 - 103